TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Ame Bioscience AS
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
3,847
|
14,166
|
18,243 |
Financial expenses |
15
|
68
|
26 |
Earnings before taxes |
720
|
2,910
|
4,363 |
Total assets |
3,510
|
5,723
|
14,531 |
Current assets |
3,507
|
5,718
|
14,524 |
Current liabilities |
821
|
772
|
11,700 |
Equity capital |
2,689
|
4,951
|
2,830 |
- share capital |
66
|
71
|
75 |
Employees (average) | 1 | 1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
76.6%
|
86.5%
|
19.5% |
Turnover per employee | 3,847 | 18,243 | |
Profit as a percentage of turnover |
18.7%
|
20.5%
|
23.9% |
Return on assets (ROA) |
20.9%
|
52.0%
|
30.2% |
Current ratio |
427.2%
|
740.7%
|
124.1% |
Return on equity (ROE) |
26.8%
|
58.8%
|
154.2% |
Change turnover |
-9,448
|
-3,120
|
17,058 |
Change turnover % |
-71%
|
-18%
|
1439% |
Chg. No. of employees | 0 | ||
Chg. No. of employees % | 0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.